BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 179765)

  • 1. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of blood platelet function by cyclic nucleotides.
    Haslam RJ; Davidson MM; Davies T; Lynham JA; McClenaghan MD
    Adv Cyclic Nucleotide Res; 1978; 9():533-52. PubMed ID: 208396
    [No Abstract]   [Full Text] [Related]  

  • 3. Initial biochemical responses of platelets to stimulation.
    Mills DC
    Ciba Found Symp; 1975; 35():153-73. PubMed ID: 179766
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of dipyridamole on human platelets.
    Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
    Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet suppressive drugs (author's transl)].
    Shio H; Kameyama M
    No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandins and platelet function.
    Salzman EW
    Adv Prostaglandin Thromboxane Res; 1976; 2():767-80. PubMed ID: 185888
    [No Abstract]   [Full Text] [Related]  

  • 10. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic nucleotides and aggregation in platelets of spontaneously hypertensive rats.
    Hamet P; Fraysse J; Franks DJ
    Circ Res; 1978 Oct; 43(4):583-91. PubMed ID: 210976
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 14. Cadmium-induced platelet hypersensitivity to aggregating agents.
    Caprino L; Togna G; Togna AR
    Pharmacol Res Commun; 1979 Oct; 11(9):731-7. PubMed ID: 231263
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action.
    Shtacher G; Crowley HJ; Dalton C
    Biochem Pharmacol; 1976 May; 25(9):1045-50. PubMed ID: 1267850
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 19. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid.
    Davies T; Davidson MM; McClenaghan MD; Say A; Haslam RJ
    Thromb Res; 1976 Oct; 9(4):387-405. PubMed ID: 185743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.